Virus-X paper

ArcticZymes was one of the partners in the EU Horizon2020 Virus-X biodiscovery research project. This paper describes the efforts of the consortium.

ArcticZymes launches SAN HQ 2.0

ArcticZymes is pleased to announce the launch of the second generation of its SAN HQ enzyme, SAN HQ 2.0. You can read the full Press release here. You can request a quote today by contacting your local Business Development Manager. To learn more about SAN HQ 2.0, visit the Product page, or get in touch.

ArcticZymes Technologies – Share capital increase registered

Tromsø, 21 June 2021) Reference is made to the Annual General Meeting resolution on 20th May 2021, regarding share capital increase of 1,836,717 new shares by contribution in kind. The share capital increase pertaining to the issuance of the new shares under the contribution in kind has now been registered with the Norwegian Register of Business Enterprises. ArcticZymes Technologies’ new …

Notice of Annual General Meeting

The Annual General Meeting (“AGM”) in ArcticZymes Technologies will be held on Thursday 20. May 2021 at 13.00 CET at SIVA Innovation Centre (Linken), Sykehusvegen 23, Tromsø. Due to the Corona pandemic, a number of measures are being taken to prevent the virus from spreading. The measures are implemented to ensure the health and safety of the Company’s employees, shareholders …